(BREAKING ISRAEL NEWS) — A new treatment involving transfusing the blood of young donors into older recipients is being lauded not only as a cure for disease but also as a possible treatment for reversing the effects of aging. But the unusual treatment, which evokes Biblical villains and dredges up medieval nightmares, has rabbis divided: is this a blessing or is it a curse?
Ambrosia, a biomedical startup in California, is running trials on a treatment that could help people suffering from heart disease, Alzheimer’s, and certain forms of cancer. The treatment is based on a theory called parabiosis, which involves transfusing young blood from donors aged 16-25 into recipients 35 and older. The current version of the treatment involves transfusions of plasma, the liquid part of blood that doesn’t contain any cells, from young people.
Since plasma cannot be patented, drug companies are not interested in this treatment and are not willing to fund the research. As a result, the human trials are expensive, with participants paying $8,000 per treatment.